2) adefovir dipivoxil
阿德福韦地匹福酯
1.
A new LC/MS/MS method for determination of adefovir in animal plasma was developed and validated and successfully used in the preclinical metabolism and pharmacokinetics study of adefovir dipivoxil.
本文首次建立了测定血浆中阿德福韦浓度的液相色谱-串联质谱(LC/MS/MS)法,并应用此方法对阿德福韦地匹福酯的临床前药代动力学进行了系统的研究。
3) adefovir
阿德福韦
1.
Determination of adefovir in human plasma by LC/MS/MS;
液相色谱-质谱-质谱联用法测定人血浆中阿德福韦的浓度
2.
Study of Adefovir on chronic type B hepatitis with Lamivudine resistance;
阿德福韦治疗拉米夫定耐药慢性乙型肝炎的研究
3.
Pharmacokinetic study of adefovir dipivoxil capsules by LC-MS/MS method;
LC-MS/MS法研究阿德福韦酯胶囊的人体药动学
4) Adefovir Dipivoxil
阿德福韦
1.
Mutation of HBV Polymerase Gene in HBV E Antigen (HBeAg) Positive Chronic Hepatitis B Patients during the Therapy with Adefovir Dipivoxil;
HBeAg阳性的慢性乙型肝炎患者应用阿德福韦治疗过程中HBVP区变异情况分析
2.
The effect of Adefovir dipivoxil therapy on T helper cells associated cytokines in patients with hepatitis B e antigen-positive chronic hepatitis B.;
阿德福韦对HBeAg阳性慢性乙型肝炎患者Th1和Th2相关细胞因子的影响
3.
Efficacy of adefovir dipivoxil in treating patients with hepatitis B resistant to lamivudine;
阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎的疗效观察
5) 9-PMEA
阿的福韦
6) Afovirsen
阿福韦生
补充资料:阿地福韦
分子式:C8H14N5O4P
分子量:275.20
CAS号:106941-25-7
性质:暂无
制备方法:暂无
用途:暂无
分子量:275.20
CAS号:106941-25-7
性质:暂无
制备方法:暂无
用途:暂无
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条